{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:47:37Z","timestamp":1777452457267,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"am","delay-in-days":262,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Texas Alzheimer's Research and Care Consortium Investigator Grant Program","award":["354528"],"award-info":[{"award-number":["354528"]}]},{"name":"Institute for Aging and Alzheimer's Disease Research","award":["RI6146"],"award-info":[{"award-number":["RI6146"]}]},{"name":"Institute for Aging and Alzheimer's Disease Research","award":["RI6068"],"award-info":[{"award-number":["RI6068"]}]},{"DOI":"10.13039\/100007069","name":"Oklahoma State Universit Center for Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pnpbp.2020.109930","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T13:00:50Z","timestamp":1584363650000},"page":"109930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Coronaridine congeners potentiate GABAA receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner"],"prefix":"10.1016","volume":"101","author":[{"given":"Hugo R.","family":"Arias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Luc","family":"Do Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude","family":"Do Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenglan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Anouar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Scholze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdeslam","family":"Chagraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pnpbp.2020.109930_bb0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.biocel.2011.05.011","article-title":"Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states","volume":"43","author":"Arias","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.pnpbp.2020.109930_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biocel.2015.05.015","article-title":"Coronaridine congeners inhibit human alpha3beta4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites","volume":"65","author":"Arias","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.pnpbp.2020.109930_bb0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.biocel.2017.10.006","article-title":"Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula","volume":"92","author":"Arias","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109930_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/00952990.2017.1320802","article-title":"Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes","volume":"44","author":"Brown","year":"2018","journal-title":"Am. J. Drug. Alcohol Abuse"},{"issue":"21","key":"10.1016\/j.pnpbp.2020.109930_bb0025","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra021261","article-title":"Mechanisms of actions of inhaled anesthetics","volume":"348","author":"Campagna","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2020.109930_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2017.04.002","article-title":"Methylene blue inhibits GABAA receptors by interaction with GABA binding site","volume":"1119","author":"Chen","year":"2017","journal-title":"Neuropahrmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109930_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1152\/jn.1981.45.4.621","article-title":"Chlordiazepoxide selectively potentiates GABA conductance of spinal cord and sensory neurons in cell culture","volume":"45","author":"Choi","year":"1981","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109930_bb0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0006-8993(92)90661-R","article-title":"Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies","volume":"571","author":"Deecher","year":"1992","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109930_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1527-3458.1999.tb00084.x","article-title":"(\u00b1)-18-Methoxycoronaridine: a novel iboga alkaloid congener having potential anti-addictive efficacy","volume":"5","author":"Glick","year":"1999","journal-title":"CNS Drug Rev."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2020.109930_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2011.08.001","article-title":"Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on nicotine self-administration","volume":"669","author":"Glick","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109930_bb0055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/cpdd.254","article-title":"Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients","volume":"5","author":"Glue","year":"2016","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109930_bb0060","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1152\/jn.1999.82.3.1233","article-title":"Effect of extracellular pH on GABA-activated current in rat recombinant receptors and thin hypothalamic slices","volume":"82","author":"Huang","year":"1999","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109930_bb0065","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(24)29466-0","article-title":"Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABAA) receptors: mechanism and site of action","volume":"298","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109930_bb0070","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1152\/jn.01040.2003","article-title":"Molecular basis for modulation of recombinant \u03b11\u03b22\u03b32 GABAA receptors by protons","volume":"92","author":"Huang","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.pnpbp.2020.109930_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2017.04.038","article-title":"The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites","volume":"121","author":"Huang","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109930_bb0080","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.pbb.2012.08.017","article-title":"Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice","volume":"103","author":"Ishola","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109930_bb0085","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1213\/01.ane.0000261519.04083.3e","article-title":"Increased gamma-aminobutyric acid levels in mouse brain induce loss of righting reflex, but not immobility, in response to noxious stimulation","volume":"104","author":"Katayama","year":"2007","journal-title":"Anesth. Analg."},{"issue":"20","key":"10.1016\/j.pnpbp.2020.109930_bb0090","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.180307497","article-title":"Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1\/NR2A receptors","volume":"97","author":"Low","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109930_bb0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0091-3057(03)00119-9","article-title":"Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment","volume":"75","author":"Maisonneuve","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109930_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0028-3908(01)00071-5","article-title":"Subunit-specific modulation of glycine receptors by neurosteroids","volume":"41","author":"Maksay","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.109930_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fnmol.2015.00064","article-title":"Selective potentiation of alpha 1 glycine receptors by ginkgolic acid","volume":"8","author":"Maleeva","year":"2015","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109930_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2009.04.019","article-title":"18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference","volume":"458","author":"McCallum","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109930_bb0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.109930_bb1035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nsmb.3484","article-title":"Structural basis for GABAA receptor potentiation by neurosteroids","volume":"24","author":"Miller","year":"2017","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109930_bb0120","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.1471-4159.2003.02135.x","article-title":"Subunit composition and quantitative importance of GABAA receptor subtypes in the cerebellum of mouse and rat","volume":"87","author":"P\u00f6ltl","year":"2003","journal-title":"J. Neurochem."},{"issue":"21","key":"10.1016\/j.pnpbp.2020.109930_bb0125","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1111\/bph.13277","article-title":"Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the \u03b17 nicotinic acetylcholine receptor","volume":"172","author":"Potasiewicz","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109930_bb1090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2016.00044","article-title":"Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?","volume":"9","author":"Puthenkalam","year":"2016","journal-title":"Front Mol Neurosci."},{"issue":"7282","key":"10.1016\/j.pnpbp.2020.109930_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/463743a","article-title":"Neuroscience: lack of inhibition leads to abuse","volume":"463","author":"Riegel","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109930_bb0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1523\/JNEUROSCI.4639-11.2012","article-title":"Dihydromyricetin as a novel anti-alcohol intoxication medication","volume":"32","author":"Shen","year":"2012","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109930_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","article-title":"Behavioural and pharmacological characterisation of the elevated \u201czero-maze\u201d as an animal model of anxiety","volume":"116","author":"Shepherd","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109930_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"48","key":"10.1016\/j.pnpbp.2020.109930_bb0150","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109930_bb0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/jpet.115.222802","article-title":"Amiloride and GMQ allosteric modulation of the GABAA rho1 receptor: influences of the Intersubunit site","volume":"353","author":"Snell","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109930_bb0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109930_bb0165","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-3565(25)12126-5","article-title":"U-90042, a sedative\/hypnotic compound that interacts differentially with the GABAA receptor subtypes","volume":"275","author":"Tang","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5786","key":"10.1016\/j.pnpbp.2020.109930_bb0170","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1123432","article-title":"Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice","volume":"313","author":"Weisstaub","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109930_bb0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2010.04.008","article-title":"Glycine and glycine receptor signaling in hippocampal neurons: diversity, function and regulation","volume":"91","author":"Xu","year":"2010","journal-title":"Prog. Neurobiol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461931019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461931019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:52:17Z","timestamp":1759521137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461931019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":37,"alternative-id":["S027858461931019X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109930","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronaridine congeners potentiate GABAA receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109930"}}